FDA Regulatory 2021 - The Veterinary Drug Approval Process and FDA Regulatory Oversight Training

This two-day interactive seminar online will provide attendees with an understanding of FDA’s veterinary drug approval process in 2021. The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for family pets, food-producing animals, and other animal species.
The group size is small, generally between 8 and 10 people, with plenty of opportunities to ask questions and discuss issues or challenges that the attendees have experienced.
Definitions
INAD/NADA technical sections
Some differences between human and animal drug approval process
Speaker:
Karl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food and drug industries with regard to pharmaceuticals and OTC drugs, biologics, medical devices